Omentin As an Independent Predictor of Metabolic Syndrome and Obesity Among Adolescents in Northeast China

Overview

Journal Diabetes Metab Syndr Obes

Publisher Dove Medical Press

Specialty Endocrinology

Date 2022 Dec 22

PMID 36545293

Authors

Xiaoshi Sun

Tianlian Li

Yumeng Tian

Shuying Ren

Ling Li

Ping Li

Affiliations

Soon will be listed here.

Abstract

Purpose: We investigated the association of omentin with metabolic syndrome (MetS), MetS components, and obesity in adolescents.

Methods: A total of 742 middle-school students from Liaoyang City were enrolled in this cross-sectional study using the stratified cluster sampling method. Clinical information and blood samples were collected, and serum omentin levels were measured using enzyme-linked immunosorbent assay.

Results: Mean plasma omentin levels were lower in male than in female participants (88.25 (interquartile range 63.02-133.61) vs 99.46 (interquartile range 69.08-188.35) ng/L, = 0.004). The participants were divided into four groups according to the quartile (Q) values of omentin from low to high. With increasing omentin levels from Q1 to Q4, the age of adolescents and the proportion of males gradually increased ( < 0.05), whereas the body mass index (BMI) ( < 0.05) and prevalence of MetS ( > 0.05) tended to decrease. Omentin levels were significantly and negatively correlated with waist circumference and BMI (correlation coefficients of -0.099 and -0.115, respectively). Regression analysis showed that omentin level was independently associated with the risk of MetS (Odds ratio, OR = 0.639, 95% confidence interval, CI (0.432, 0.945)), which was attributed to the association with central obesity (OR = 0.775, 95% CI (0.605, 0.993)) among MetS components. Increased omentin levels also indicated a reduced risk of obesity (OR = 0.700, 95% CI (0.563, 0.870)).

Conclusion: Omentin is an independent predictor of MetS and obesity among adolescents in northeast China.

Citing Articles

Biomarkers and Seaweed-Based Nutritional Interventions in Metabolic Syndrome: A Comprehensive Review.

Valado A, Cunha M, Pereira L Mar Drugs. 2024; 22(12).

PMID: 39728125 PMC: 11677938. DOI: 10.3390/md22120550.

Diagnostic and Prognostic Value of Serum Omentin-1 in Sepsis: A Prospective Study in Critically Ill Patients.

Karampela I, Vallianou N, Tsilingiris D, Christodoulatos G, Antonakos G, Marinou I Medicina (Kaunas). 2023; 59(5).

PMID: 37241065 PMC: 10223419. DOI: 10.3390/medicina59050833.

Valproate-Induced Metabolic Syndrome.

Shnayder N, Grechkina V, Trefilova V, Efremov I, Dontceva E, Narodova E Biomedicines. 2023; 11(5).

PMID: 37239168 PMC: 10216246. DOI: 10.3390/biomedicines11051499.

References

Jialal I, Devaraj S, Kaur H, Adams-Huet B, Bremer A . Increased chemerin and decreased omentin-1 in both adipose tissue and plasma in nascent metabolic syndrome. J Clin Endocrinol Metab. 2013; 98(3):E514-7. DOI: 10.1210/jc.2012-3673. View

Askin L, Duman H, Ozyildiz A, Tanriverdi O, Turkmen S . Association between Omentin-1 and Coronary Artery Disease: Pathogenesis and Clinical Research. Curr Cardiol Rev. 2020; 16(3):198-201. PMC: 7536812. DOI: 10.2174/1573403X16666200511085304. View

Auguet T, Quintero Y, Riesco D, Morancho B, Terra X, Crescenti A . New adipokines vaspin and omentin. Circulating levels and gene expression in adipose tissue from morbidly obese women. BMC Med Genet. 2011; 12:60. PMC: 3107780. DOI: 10.1186/1471-2350-12-60. View

Li R, Li W, Lun Z, Zhang H, Sun Z, Kanu J . Prevalence of metabolic syndrome in Mainland China: a meta-analysis of published studies. BMC Public Health. 2016; 16:296. PMC: 4818385. DOI: 10.1186/s12889-016-2870-y. View

Gupta N, Goel K, Shah P, Misra A . Childhood obesity in developing countries: epidemiology, determinants, and prevention. Endocr Rev. 2012; 33(1):48-70. DOI: 10.1210/er.2010-0028. View

Shulman G . Ectopic fat in insulin resistance, dyslipidemia, and cardiometabolic disease. N Engl J Med. 2014; 371(12):1131-41. DOI: 10.1056/NEJMra1011035. View

Zhou J, Chan L, Zhou S . Omentin: linking metabolic syndrome and cardiovascular disease. Curr Vasc Pharmacol. 2012; 12(1):136-43. DOI: 10.2174/1570161112999140217095038. View

Magge S, Goodman E, Armstrong S . The Metabolic Syndrome in Children and Adolescents: Shifting the Focus to Cardiometabolic Risk Factor Clustering. Pediatrics. 2017; 140(2). DOI: 10.1542/peds.2017-1603. View

Pacheco L, Blanco E, Burrows R, Reyes M, Lozoff B, Gahagan S . Early Onset Obesity and Risk of Metabolic Syndrome Among Chilean Adolescents. Prev Chronic Dis. 2017; 14:E93. PMC: 5645192. DOI: 10.5888/pcd14.170132. View

10.

Dagdelen D, Karadag A, Kasapoglu E, Wang J, Erman H . Correlation of metabolic syndrome with serum omentin-1 and visfatin levels and disease severity in psoriasis and psoriatic arthritis. Dermatol Ther. 2020; 33(6):e14378. DOI: 10.1111/dth.14378. View

11.

. [Body mass index reference norm for screening overweight and obesity in Chinese children and adolescents]. Zhonghua Liu Xing Bing Xue Za Zhi. 2004; 25(2):97-102. View

12.

Yang R, Lee M, Hu H, Pray J, Wu H, Hansen B . Identification of omentin as a novel depot-specific adipokine in human adipose tissue: possible role in modulating insulin action. Am J Physiol Endocrinol Metab. 2006; 290(6):E1253-61. DOI: 10.1152/ajpendo.00572.2004. View

13.

Tsiotra P, Halvatsiotis P, Patsouras K, Maratou E, Salamalekis G, Raptis S . Circulating adipokines and mRNA expression in adipose tissue and the placenta in women with gestational diabetes mellitus. Peptides. 2018; 101:157-166. DOI: 10.1016/j.peptides.2018.01.005. View

14.

Shang F, Wang J, Liu X, Zheng Q, Xue Y, Wang B . Serum omentin-1 levels are inversely associated with the presence and severity of coronary artery disease in patients with metabolic syndrome. Biomarkers. 2011; 16(8):657-62. DOI: 10.3109/1354750X.2011.622789. View

15.

Hudish L, Reusch J, Sussel L . β Cell dysfunction during progression of metabolic syndrome to type 2 diabetes. J Clin Invest. 2019; 129(10):4001-4008. PMC: 6763241. DOI: 10.1172/JCI129188. View

16.

Fahed G, Aoun L, Zerdan M, Allam S, Zerdan M, Bouferraa Y . Metabolic Syndrome: Updates on Pathophysiology and Management in 2021. Int J Mol Sci. 2022; 23(2). PMC: 8775991. DOI: 10.3390/ijms23020786. View

17.

de Souza Batista C, Yang R, Lee M, Glynn N, Yu D, Pray J . Omentin plasma levels and gene expression are decreased in obesity. Diabetes. 2007; 56(6):1655-61. DOI: 10.2337/db06-1506. View

18.

Vu A, Sidhom M, Bredbeck B, Kosmiski L, Aquilante C . Evaluation of the relationship between circulating omentin-1 concentrations and components of the metabolic syndrome in adults without type 2 diabetes or cardiovascular disease. Diabetol Metab Syndr. 2014; 6(1):4. PMC: 3901757. DOI: 10.1186/1758-5996-6-4. View

19.

Siegrist M, Heitkamp M, Braun I, Vogg N, Haller B, Langhof H . Changes of omentin-1 and chemerin during 4 weeks of lifestyle intervention and 1 year follow-up in children with obesity. Clin Nutr. 2021; 40(11):5648-5654. DOI: 10.1016/j.clnu.2021.09.042. View

20.

Ford E, Li C, Zhao G, Pearson W, Mokdad A . Prevalence of the metabolic syndrome among U.S. adolescents using the definition from the International Diabetes Federation. Diabetes Care. 2007; 31(3):587-9. DOI: 10.2337/dc07-1030. View